Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine added to propofol sedation for ambulatory colonoscopy recovery
ChiCTR2200066353Phase 4Not yet recruiting
- Sponsor
- Fujian Provincial Hospital
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine and propofol in Intestinal disease (2 arms), sponsored by Fujian Provincial Hospital. Primary endpoint: Recovery in the cognitive domain on postoperative day 3. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
esketaminepropofol
03
Conditions
Intestinal disease
Beyond the preview
Go deeper on ChiCTR2200066353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066353.